Trials / Completed
CompletedNCT07028671
Exploratory Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms
Exploratory Pilot Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms Among Chinese Suffers Using Real-world Evidence: A Non-interventional, Prospective, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to understand the effectiveness and safety of Motilium among study participants with dyspepsia-related symptoms in real-world settings in China.
Conditions
Timeline
- Start date
- 2023-12-28
- Primary completion
- 2024-03-26
- Completion
- 2024-03-26
- First posted
- 2025-06-19
- Last updated
- 2025-06-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07028671. Inclusion in this directory is not an endorsement.